How do you manage a patient with widely metastatic serous endometrial cancer whose disease is stable after completion of 6 cycles of chemotherapy + immunotherapy?

She continues to have hypermetabolic nodes in bilateral external iliac and axillary nodes, as well as a hypermetabolic 16cm uterus.